|
|
||||||||
J Thorac Cardiovasc Surg 2005;129:831-837
© 2005 The American Association for Thoracic Surgery
Evolving Technology |
a Service de Cardiologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
b Institut National de la Santé et de la Recherche Médicale EMIU 0016, Faculté de Necker Enfants Malades, Paris, France
c Cardiothoracic Unit, Great Ormond Street Hospital, London, United Kingdom
Received for publication August 31, 2004; revisions received October 19, 2004; accepted for publication October 28, 2004. * Address for reprints: Younes Boudjemline, MD, Service de Cardiologie Pédiatrique, Hôpital Necker Enfants Malades, 149 rue de Sèvres, 75015 Paris Cedex, France (E-mail: younes.boudjemline{at}nck.ap-hop-paris.fr).
BACKGROUND: Percutaneous pulmonary valve replacement has recently been introduced and is under investigation in humans. This technique is, however, limited to patients with a right ventricular outflow tract that does not exceed 22 mm in diameter. We report our experience of off-pump pulmonary valve replacement using a hybrid approach in animals with large right ventricular outflow tracts.
METHODS: Eight ewes were included in the protocol and were equally divided into 2 groups. A left thoracotomy was first performed, and the main pulmonary artery was banded by using 2 radiopaque rings with a diameter of 18 mm that allowed for further pulmonary valve replacement. We then intended to implant a valved stent either percutaneously (group 1) or through a transventricular approach (group 2). All animals were killed after valve implantation. The operation allowed the pulmonary diameter to be reduced from 30 to 17.6 mm.
RESULTS: The right ventricular pressure did not significantly increase after reduction of the pulmonary artery diameter (25 vs 36 mm Hg). Subsequent pulmonary valve replacement through a percutaneous or a transventricular approach was always possible without any requirement for extracorporeal circulation. All devices were successfully delivered inside the pulmonary artery banding and were functioning perfectly at early evaluation.
CONCLUSIONS: Implantation of a pulmonary valve is possible in ewes through a hybrid approach when the right ventricular outflow tract exceeds 22 mm in diameter. This involves both surgeons and interventionists and allows for a staged procedure in which the valvulation is performed percutaneously or, for a combined hybrid approach, in which the valve is implanted off pump transventricularly during the same operation.
This article has been cited by other articles:
![]() |
R. Kozlik-Feldmann, N. Lang, R. Aumann, A. Lehner, D. Rassoulian, R. Sodian, C. Schmitz, M. Hinterseer, R. Hinkel, E. Thein, et al. Patch closure of muscular ventricular septal defects with a new hybrid therapy in a pig model. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1597 - 1603. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schreiber, J. Horer, M. Vogt, S. Fratz, M. Kunze, C. Galm, A. Eicken, and R. Lange A new treatment option for pulmonary valvar insufficiency: first experiences with implantation of a self-expanding stented valve without use of cardiopulmonary bypass Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 26 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Attmann, R. Quaden, T. Jahnke, S. Muller-Hulsbeck, A. Boening, J. Cremer, and G. Lutter Percutaneous Pulmonary Valve Replacement: 3-Month Evaluation of Self-Expanding Valved Stents Ann. Thorac. Surg., August 1, 2006; 82(2): 708 - 713. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |